These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37666529)

  • 21. Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
    Rau TT; Bettschen E; Büchi C; Christe L; Rohner A; Müller MD; Carlson JW; Imboden S; Zlobec I
    Mod Pathol; 2021 Jan; 34(1):222-232. PubMed ID: 32728223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.
    Loukovaara M; Bützow R; Staff S; Mäenpää M; Faltinová M; Lassus H; Veijalainen O; Grönvall M; Vaalavirta L; Kuikka E; Haataja M; Urpilainen E; Simojoki M; Anttila M; Auranen A
    Int J Gynecol Cancer; 2023 Nov; 33(11):1807-1811. PubMed ID: 37813479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SENECA study: staging endometrial cancer based on molecular classification.
    Chacon E; Boria F; Lyer RR; Fanfani F; Malzoni M; Bretová P; Luzarraga Aznar A; Fruscio R; Jedryka MA; Tóth R; Perrone AM; Kakkos A; Cristóbal Quevedo I; Congedo L; Zanagnolo V; Fernandez-Gonzalez S; Ferro B; Narducci F; Hovhannisyan T; Aksahin E; Cardenas L; Oliver MR; Nozaleda G; Arnaez M; Misiek M; Ferrero A; Pain FA; Zarragoitia J; Diaz C; Ceppi L; Mehdiyev S; Roldán-Rivas F; Guijarro-Campillo AR; Amengual J; Manzour N; Sanchez Lorenzo L; Núñez-Córdoba JM; Gonzalez Martin A; Minguez JA; Chiva L;
    Int J Gynecol Cancer; 2024 Sep; 34(9):1313-1321. PubMed ID: 39153831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of lympho-vascular space invasion in different molecular subtypes of endometrial carcinoma].
    Li YM; Zhai ZY; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2024 Aug; 59(8):617-627. PubMed ID: 39187409
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 26. Real-World Data Assessing the Impact of Lymphovascular Space Invasion on the Diagnostic Performance of Sentinel Lymph Node Mapping in Endometrial Cancer.
    Buechi CA; Siegenthaler F; Sahli L; Papadia A; Saner FAM; Mohr S; Rau TT; Solass W; Imboden S; Mueller MD
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status.
    de Freitas D; Aguiar FN; Anton C; de Almeida DC; Bacchi CE; Carvalho JP; Carvalho FM
    Heliyon; 2023 Jun; 9(6):e17495. PubMed ID: 37408903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
    Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
    J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
    Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.
    Similä-Maarala J; Soovares P; Pasanen A; Ahvenainen T; Vahteristo P; Bützow R; Lassus H
    Gynecol Oncol; 2022 Jun; 165(3):577-584. PubMed ID: 35370008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of the Immune Microenvironment in Endometrial Cancer.
    Lee M; Jung W; Kang J; Lee KH; Lee SJ; Hong SH; Kang J; Lee A
    Lab Invest; 2024 Sep; 104(9):102126. PubMed ID: 39174007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapy.
    Zhang Y; Yang R; Xu C; Zhang Y; Deng M; Wu D; Tang F; Liu X; Han Y; Zhan Y; Miao J
    Pathol Res Pract; 2022 Aug; 236():153990. PubMed ID: 35749914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Santoro A; Raimondo D; Angelico G; Valente M; Arciuolo D; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Seracchioli R; Zannoni GF
    Gynecol Oncol; 2021 Sep; 162(3):804-808. PubMed ID: 34266691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial Cancer-Immune Phenotypes Predict Shorter Recurrence-Free Survival in the No Specific Molecular Profile Molecular Subtype of Endometrial Carcinoma.
    de Biase D; Lenzi J; Ceccarelli C; Maloberti T; Grillini M; Coadǎ CA; Zamagni C; De Iaco P; Perrone AM; Santini D; Köbel M; Lee CH; Tallini G; De Leo A
    Mod Pathol; 2024 Sep; 38(1):100624. PubMed ID: 39326496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
    Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.
    Jamieson A; Thompson EF; Huvila J; Leung S; Lum A; Morin C; Ennour-Idrissi K; Sebastianelli A; Renaud MC; Gregoire J; Huntsman DG; Gilks CB; Plante M; Grondin K; McAlpine JN
    Gynecol Oncol; 2022 May; 165(2):376-384. PubMed ID: 35504673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
    Krämer P; Talhouk A; Brett MA; Chiu DS; Cairns ES; Scheunhage DA; Hammond RFL; Farnell D; Nazeran TM; Grube M; Xia Z; Senz J; Leung S; Feil L; Pasternak J; Dixon K; Hartkopf A; Krämer B; Brucker S; Heitz F; du Bois A; Harter P; Kommoss FKF; Sinn HP; Heublein S; Kommoss F; Vollert HW; Manchanda R; de Kroon CD; Nijman HW; de Bruyn M; Thompson EF; Bashashati A; McAlpine JN; Singh N; Tinker AV; Staebler A; Bosse T; Kommoss S; Köbel M; Anglesio MS
    Clin Cancer Res; 2020 Oct; 26(20):5400-5410. PubMed ID: 32737030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
    Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
    World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.